Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative Colitis

Brendan Boyle1, Margaret H Collins, Zhu Wang

  • 1*Nationwide Children's Hospital, Columbus †Cincinnati Children's Hospital Medical Center, Cincinnati, OH ‡Connecticut Children's Medical Center, Hartford, CT §Children's Hospital of Eastern Ontario, Ottawa ∥Hospital for Sick Children, Toronto, ON, Canada ¶Emory Children's Center, Atlanta, GA #Cohen Children's Medical Center, New Hyde Park ‡‡Goryeb Children's Hospital/Atlantic Health, Morristown §§Women & Children's Hospital of Buffalo WCHOB, Buffalo, NY **Hasbro Children's Hospital, Providence, RI ††Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA ∥∥Riley Children's Hospital Indiana University School of Medicine, Indianapolis, IN ¶¶University of California, San Francisco, CA ##UT Southwestern, Dallas, TX ***Children's Hospital of Philadelphia, Philadelphia, PA †††Medical College of Wisconsin, Milwaukee, WI ‡‡‡Boston Children's Hospital, Boston, MA.

Insights

Pediatric ulcerative colitis (UC) in children shows common rectal inflammation and chronic changes. Low eosinophilic inflammation and surface villiform changes may correlate with severe disease activity.

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Pathology
  • Inflammatory Bowel Disease Research

Background:

  • Ulcerative colitis (UC) is a chronic inflammatory bowel disease affecting the colon.
  • Early histological characterization in pediatric UC is crucial for understanding disease progression.
  • The PROTECT Study provides a unique inception cohort for pediatric UC research.

Purpose of the Study:

  • To characterize rectal histology in newly diagnosed pediatric ulcerative colitis (UC) patients.
  • To investigate the relationship between histological findings and clinical disease severity indices.
  • To identify potential histological markers associated with UC activity in children.

Main Methods:

  • Analysis of baseline rectal biopsies from 369 children newly diagnosed with UC (age ≤ 17).
  • Histological evaluation included acute/chronic inflammation, eosinophilic inflammation, and chronic changes.
  • Correlation of histological findings with Mayo endoscopy subscore and Pediatric Ulcerative Colitis Activity Index (PUCAI).

Main Results:

  • High prevalence of cryptitis (89%), crypt abscesses (25%), and eosinophilic inflammation (58%).
  • Crypt distortion/atrophy was observed in 98% of specimens.
  • Severe clinical scores (Mayo, PUCAI) were associated with specific histological features, including basal plasmacytosis, lymphoid aggregates, surface villiform changes, and notably, lower eosinophilic inflammation.

Conclusions:

  • Acute, chronic, and eosinophilic inflammation are common in newly diagnosed pediatric UC.
  • Histological findings like basal plasmacytosis, lymphoid aggregates, and villiform changes correlate with disease severity.
  • The clinical significance of low eosinophilic inflammation and villiform changes in pediatric UC warrants further investigation.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
668
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
839
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
977
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.3K